Carcinogenic agents table

Agents Classified by the IARC Monographs, Volumes 1—122

CAS No.

Agent

Group

Volume

Year

Additional information

50-00-0

Formaldehyde

1

Sup 7, 62, 88, 100F

2012

50-06-6

Phénobarbital

2B

Sup 7, 79

2001

50-07-7

Mitomycin C

2B

10, Sup 7

1987

50-18-0

6055-19-2

Cyclophosphamide

1

26, Sup 7, 100A

2012

50-29-3

DDT (4,4'-dichlorodiphenyltrichloroethane)

2A

Sup 7, 53, 113

2018

50-32-8

Benzo[a ]pyrene

1

Sup 7, 92, 100F

2012

NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data

50-33-9

Phenylbutazone

3

13, Sup 7

1987

50-41-9

Clomiphene citrate

3

21, Sup 7

1987

50-44-2

6-Mercaptopurine

3

26, Sup 7

1987

50-55-5

Reserpine

3

24, Sup 7

1987

50-76-0

Actinomycin D

3

10, Sup 7

1987

51-02-5

Pronetalol hydrochloride

3

13, Sup 7

1987

51-03-6

Piperonyl butoxide

3

30, Sup 7

1987

51-18-3

2,4,6-Tris(1-aziridinyl)-i -triazine

3

9, Sup 7

1987

51-21-8

5-Fluorouracil

3

26, Sup 7

1987

51-52-5

Propylthiouracil

2B

Sup 7, 79

2001

51-75-2

Nitrogen mustard

2A

9, Sup 7

1987

51-79-6

Ethyl carbamate (Urethane)

2A

7, Sup 7, 96

2010

52-01-7

Spironolactone

3

Sup 7, 79

2001

52-24-4

Thiotepa

1

Sup 7, 50, 100A

2012

52-46-0

Apholate

3

9, Sup 7

1987

52-68-6

Trichlorfon

3

30, Sup 7

1987

53-03-2

Prednisone

3

26, Sup 7

1987

53-70-3

Dibenz[a, h ]anthracene

2A

Sup 7, 92

2010

NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data

54-05-7

Chloroquine

3

13, Sup 7

1987

54-31-9

Furosemide (Frusemide)

3

50

1990

54-85-3

Isonicotinic acid hydrazide (Isoniazid)

3

4, Sup 7

1987

55-18-5

N -Nitrosodiethylamine

2A

17, Sup 7

1987

NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data

55-98-1

1,4-Butanediol dimethanesulfonate (see Busulfan)

55-98-1

Busulfan

1

4, Sup 7, 100A

2012

55-98-1

Myleran (see Busulfan)

56-04-2

Methylthiouracil

2B

Sup 7, 79

2001

56-23-5

Carbon tetrachloride

2B

20, Sup 7, 71

1999

56-25-7

Cantharidin

3

10, Sup 7

1987

56-38-2

Parathion

2B

30, Sup 7, 112

2017

56-53-1

Diethylstilbestrol

1

21, Sup 7, 100A

2012

56-55-3

Benz[a ]anthracene

2B

92, Sup 7

2010

56-75-7

Chloramphenicol

2A

Sup 7, 50

1990

NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data

57-06-7

Allyl isothiocyanate

3

73, Sup 7

1999

57-14-7

1,1 -Dimethylhydrazine

2B

4, Sup 7, 71

1999

57-39-6

Tris(2-methyl-1-aziridinyl)phosphine oxide

3

9, Sup 7

1987

57-41-0

Phenytoin

2B

Sup 7, 66

1996

57-57-8

beta-Propiolactone

2B

4, Sup 7, 71

1999

57-68-1

Sulfamethazine

3

79

2001

NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data

57-74-9

Chlordane

2B

Sup 7, 53, 79

2001

57-88-5

Cholesterol

3

31, Sup 7

1987

58-08-2

Caffeine

3

51

1991

58-14-0

Pyrimethamine

3

13, Sup 7

1987

58-55-9

Theophylline

3

51

1991

58-89-9

Lindane (see also Hexachlorocyclohexanes)

1

113

2018

58-93-5

Hydrochlorothiazide

2B

50, 108

2016

59-05-2

Methotrexate

3

26, Sup 7

1987

59-87-0

Nitrofural (Nitrofurazone)

3

50

1990

59-89-2

N -Nitrosomorpholine

2B

17, Sup 7

1987

60-09-3

para -Aminoazobenzene

2B

8, Sup 7

1987

60-11-7

para -Dimethylaminoazobenzene

2B

8, Sup 7

1987

60-35-5

Acetamide

2B

7, Sup 7, 71

1999

60-56-0

Methimazole

3

79

2001

60-57-1

Dieldrin (see Dieldrin, and aldrin metabolized to dieldrin)

60-57-1, 309-00-2

Dieldrin, and aldrin metabolized to dieldrin

2A

5, Sup 7, 117

In prep.

61-57-4

Niridazole

2B

13, Sup 7

1987

61-82-5

Amitrole

3

79, Sup 7

2001

NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data

62-44-2

Phenacetin

1

24, Sup 7, 100A

2012

NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data

62-50-0

Ethyl methanesulfonate

2B

7, Sup 7

1987

62-53-3

Aniline

3

27, Sup 7

1987